Abstract
Physiological and chemically induced modifications to nucleosides are common in both DNA and RNA. Physiological forms of these modifications play critical roles in gene expression, yet aberrant marks, if left unrepaired, may be associated with increased genome instability. Due to the low prevalence of these marks in most samples of interest, a highly sensitive method is needed for their detection and quantitation. High-performance liquid chromatography, coupled to mass spectrometry (HPLC-MS), provides this high degree of sensitivity while also being adaptable to nearly any modified nucleoside of interest and still maintaining exquisite specificity. In this chapter, we demonstrate how to use HPLC-MS to analyze the catalytic activity of a nucleic acid demethylase, to quantify the prevalence of N6-methyladenosine from RNA, and to determine the kinetics of alkylation damage repair.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome—biological and translational implications. Nat Rev Cancer 11(10):726–734
Shen L et al (2014) Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu Rev Biochem 83:585–614
Goll MG, Bestor TH (2005) Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74:481–514
Wu X, Zhang Y (2017) TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet 18(9):517
Liu J et al (2014) A METTL3–METTL14 complex mediates mammalian nuclear RNA N 6-adenosine methylation. Nat Chem Biol 10(2):93–95
Jia G, Fu Y, Zhao X, Dai Q, Zheng G et al (2011) N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7:885–887
Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM et al (2013) ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 49:18–29
Phizicky EM, Hopper AK (2010) tRNA biology charges to the front. Genes Dev 24(17):1832–1860
Rošić S et al (2018) Evolutionary analysis indicates that DNA alkylation damage is a byproduct of cytosine DNA methyltransferase activity. Nat Genet 50(3):452–459
Strauss B, Scudiero D, Henderson E (1975) The nature of the alkylation lesion in mammalian cells. In: Molecular mechanisms for repair of DNA. Springer, Boston, MA, pp 13–24
Li X et al (2017) Base-resolution mapping reveals distinct m1A methylome in nuclear-and mitochondrial-encoded transcripts. Mol Cell 68(5):993–1005
Xu L et al (2017) Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans. J Biol Chem 292(35):14695–14703
Zhang L-H et al (2020) The SUMOylated METTL8 induces R-loop and tumorigenesis via m3C. iScience 23(3):100968
Fu D, Calvo J, Samson L (2012) Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer 12:104–120. https://doi.org/10.1038/nrc3185
Aas P, Otterlei M, Falnes P et al (2003) Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 421:859–863. https://doi.org/10.1038/nature01363
Drabløs F et al (2004) Alkylation damage in DNA and RNA—repair mechanisms and medical significance. DNA Repair 3(11):1389–1407
Dango S, Mosammaparast N, Sowa ME, Xiong L-J, Wu F, Park K, Rubin M, Gygi S, Harper JW, Shi Y (2011) DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation. Mol Cell 44:373–384
Barciszewska AM, Murawa D et al (2007) Analysis of 5-methylcytosine in DNA of breast and colon cancer tissues. IUBMB Life 59(12):765–770. https://doi.org/10.1080/15216540701697412
Michalak M, Plitta-Michalak BP et al (2015) Global 5-methylcytosine alterations in DNA during ageing of Quercus robur seeds. Ann Bot 116(3):369–376. https://doi.org/10.1093/aob/mcv104
Azimzadeh P, Asadzadeh Aghdaei H, Tarban P, Akhondi MM, Shirazi A, Khorram Khorshid HR (2016) Comparison of three methods for mitochondria isolation from human liver cell line (HepG2). Gastroenterol Hepatol Bed Bench 9(2):105–113
Acknowledgments
Work in our laboratory is supported the by the NIH (R01 CA193318, R01 CA227001, and P01 CA092584), the American Cancer Society research scholar program (RSG-18-156-01-DMC), and the Alvin J. Siteman Cancer Center Investment Program, which is supported by the Foundation for Barnes-Jewish Hospital Cancer Frontier Fund and the National Cancer Institute, Cancer Support Grant P30 CA091842.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rodell, R., Tsao, N., Ganguly, A., Mosammaparast, N. (2022). Use of High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) to Quantify Modified Nucleosides. In: Mosammaparast, N. (eds) DNA Damage Responses. Methods in Molecular Biology, vol 2444. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2063-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2063-2_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2062-5
Online ISBN: 978-1-0716-2063-2
eBook Packages: Springer Protocols